SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rémy Duléry, Mohamad Mohty, Alain Duhamel, Marie Robin, Yves Beguin, Mauricette Michallet, Stéphane Vigouroux, Bruno Lioure, Alice Garnier, Jean El Cheikh, Claude-Eric Bulabois, Anne Huynh, Jacques-Olivier Bay, Etienne Daguindau, Patrice Ceballos, Laurence Clément, Charles Dauriac, Natacha Maillard, Faezeh Legrand, Jérôme Cornillon, Gaëlle Guillerm, Sylvie François, Simona Lapusan, Patrice Chevallier, Gandhi Damaj, Ibrahim Yakoub-Agha, Antithymocyte Globulin before Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Study from the French Society of Bone Marrow Transplantation and Cellular Therapy, Biology of Blood and Marrow Transplantation, 2014, 20, 5, 646

    CrossRef

  2. 2
    Raynier Devillier, Sabine Fürst, Jean El-Cheikh, Luca Castagna, Samia Harbi, Angela Granata, Roberto Crocchiolo, Claire Oudin, Bilal Mohty, Reda Bouabdallah, Christian Chabannon, Anne-Marie Stoppa, Aude Charbonnier, Florence Broussais-Guillaumot, Boris Calmels, Claude Lemarie, Jèrôme Rey, Norbert Vey, Didier Blaise, Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, 2014, 20, 3, 370

    CrossRef

  3. 3
    Giuseppe Visani, Michele Malagola, Barbara Guiducci, Moira Lucesole, Federica Loscocco, Elisa Gabucci, Stefania Paolini, Pier Paolo Piccaluga, Alessandro Isidori, Conditioning regimens in acute myeloid leukemia, Expert Review of Hematology, 2014, 7, 4, 465

    CrossRef

  4. 4
    S.P. Chantepie, A.C. Gac, O. Reman, Feasibility of the fludarabine busulfan 3 days and ATG 2 days reduced toxicity conditioning in 51 allogeneic hematopoietic stem cell transplantation: A single-center experience, Leukemia Research, 2014, 38, 5, 569

    CrossRef

  5. 5
    Raynier Devillier, Samia Harbi, Sabine Fürst, Roberto Crocchiolo, Jean El-Cheikh, Luca Castagna, Anne Etienne, Boris Calmels, Claude Lemarie, Thomas Prebet, Angela Granata, Aude Charbonnier, Jérôme Rey, Christian Chabannon, Catherine Faucher, Norbert Vey, Didier Blaise, Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation, Biology of Blood and Marrow Transplantation, 2014,

    CrossRef

  6. 6
    B K Hamilton, L Rybicki, J Dabney, L McLellan, H Haddad, L Foster, D Abounader, M Kalaycio, R Sobecks, R Dean, H Duong, B T Hill, B J Bolwell, E A Copelan, Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation, Bone Marrow Transplantation, 2014,

    CrossRef

  7. 7
    L Castagna, R Crocchiolo, S Furst, J E Cheikh, B Esterni, A Granata, A Stoppa, R Boubdallah, D Coso, N Vey, A Charbonniere, C Lemarie, C Faucher, C Chabannon, D Blaise, Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors, Bone Marrow Transplantation, 2014,

    CrossRef

  8. 8
    Yi-Bin Chen, Erin Coughlin, Kevin F. Kennedy, Edwin P. Alyea, Philippe Armand, Eyal C. Attar, Karen K. Ballen, Corey Cutler, Bimalangshu R. Dey, John Koreth, Steven L. McAfee, Thomas R. Spitzer, Joseph H. Antin, Robert J. Soiffer, Vincent T. Ho, Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia, Biology of Blood and Marrow Transplantation, 2013, 19, 6, 981

    CrossRef

  9. 9
    Amandine Le Bourgeois, Catherine Mohr, Thierry Guillaume, Jacques Delaunay, Florent Malard, Marion Loirat, Pierre Peterlin, Nicolas Blin, Viviane Dubruille, Beatrice Mahe, Thomas Gastinne, Steven Le Gouill, Philippe Moreau, Mohamad Mohty, Lucie Planche, Laurence Lode, Marie-Christine Bene, Patrice Chevallier, Comparison of Outcomes after Two Standards-of-Care Reduced-Intensity Conditioning Regimens and Two Different Graft Sources for Allogeneic Stem Cell Transplantation in Adults with Hematologic Diseases: A Single-Center Analysis, Biology of Blood and Marrow Transplantation, 2013, 19, 6, 934

    CrossRef

  10. 10
    Emmanuelle Assouline, Roberto Crocchiolo, Thomas Prebet, Florence Broussais, Diane Coso, Marc Gamerre, Norbert Vey, Didier Blaise, Blandine Courbiere, Impact of Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation on Women's Fertility, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 6, 704

    CrossRef

  11. 11
    C. Craddock, Pharmacological methods to reduce disease recurrence, Hematology, 2013, 2013, 1, 63

    CrossRef

  12. 12
    Markus Y. Mapara, The Quest for the Optimal Conditioning Regimen: Some Answers, More Questions, Biology of Blood and Marrow Transplantation, 2013, 19, 9, 1275

    CrossRef